Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.
نویسندگان
چکیده
BACKGROUND Since 1998 Municipal Public Health Services (MPHSs) in The Netherlands carried out Hepatitis A (HAV) vaccination programs for Turkish and Moroccan children to reduce import and secondary HAV infections. The aim of this study was to assess the effects of the programs on HAV incidence. METHODS MPHSs were questioned about HAV vaccination programs for migrant children. Notification data of HAV over the period 1995-2006 were analysed. RESULTS Since 1998, 19 MPHSs (58%) organized vaccination programs for Turkish and Moroccan children. A large variation in the range of activities in HAV vaccination programs was observed. In The Netherlands, HAV incidence declined, from 6.5 per 100,000 inhabitants in 1995 to 1.3 in 2005. HAV incidence in children of Turkish and Moroccan decent declined from 70.3 per 100,000 in 2000 to 13.5 per 100,000 in 2005. Regions where MPHSs organized vaccination campaigns had the steepest decline in HAV incidence. CONCLUSION The decline in HAV incidence in The Netherlands coincided with that observed for the rest of Europe. Therefore, also other causes than the enhanced vaccination programs could have contributed to this effect. At present, low priority is placed on continuing these HAV vaccination programs, as in areas without enhanced programs the incidence also declined to very low levels. Because HAV is still endemic in Morocco and Turkey, it remains important that all travellers to these countries are vaccinated against HAV, regardless of their country of origin.
منابع مشابه
Persistence of immunity to hepatitis B vaccine as infants, 17 years earlier
Background: In Iran scince 1992, hepatitis B vaccination was a part of the national vaccination program. Hepatitis B vaccination is effective in the epidemiology of hepatitis B. The aim ofthis study was to evaluate the long – term persistence of immunity. Methods: This cross-sectional analytical study was conducted on children and adolescents aged between 6-18 years in Birjand, who recei...
متن کاملهپاتیت ویروسی و پیشگیری از آن وضعیت موجود با نگاهی به آینده
Viral hepatitis is the most common cause of liver disease in the world. In the past 30 years, highly effective vaccines have become available for two of the five hepatitis viruses, and where implemented, vaccination has become a key component of hepatitis prevention. To provide a current review and critical analysis of the viral hepatitis, A (HAV) and B (HBV) prevention by immunization has be...
متن کاملHepatitis B vaccine immunogenicity in Kerman 12 months infants
Introduction: Infection with HBV is the most common chronic viral infection and mortality in children. Prevention of this infection with vaccination is vital. This study was done to compare the antibody level in post hepatitis B vaccination in children with 12 months age. Materials and Methods:This descriptive study was carreid out on healthy 120 children ...
متن کاملIntra-familial Transmission of Hepatitis B Virus Infection in Arak, Central Iran
Background: The household transmission of hepatitis B virus (HBV) is a major health problem. High incidence of HBV infection is observed within the household contacts of HBV carriers. We aimed to evaluate serological markers of hepatitis B infection among family members of HBV carriers in Arak, central Iran. Methods<stron...
متن کاملAnti-HBs Response and its Protective Effect in Children and Adults Receiving Hepatitis B Recombinant Vaccine in Tehran
Background: Following WHO recommendation, HBV vaccination has been integrated into EPI program in Iran since 1996. Objective: To evaluate the immunogenicity and protective effect of HB vaccine (recombinant Heberbiovac ,Cuba ) in vaccinated children and adults . Methods: A total of 542 cases (340 children and 202 adults) were vaccinated using a three-doses schedule of zero, one and six month. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- European journal of public health
دوره 19 3 شماره
صفحات -
تاریخ انتشار 2009